title: Response to Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al.
authors: Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH.
authors: Mohamed
authors: M
authors: Bassiouny
authors: Walid
authors: W
authors: Saliba
authors: John
authors: J
authors: Rickard
authors: Mingyuan
authors: M
authors: Shao
authors: Albert
authors: A
authors: Sey
authors: Mariam
authors: M
authors: Diab
authors: David O
authors: DO
authors: Martin
authors: Ayman
authors: A
authors: Hussein
authors: Maurice
authors: M
authors: Khoury
authors: Bernard
authors: B
authors: Abi-Saleh
authors: Samir
authors: S
authors: Alam
authors: Jay
authors: J
authors: Sengupta
authors: P Peter
authors: PP
authors: Borek
authors: Bryan
authors: B
authors: Baranowski
authors: Mark
authors: M
authors: Niebauer
authors: Thomas
authors: T
authors: Callahan
authors: Niraj
authors: N
authors: Varma
authors: Mina
authors: M
authors: Chung
authors: Patrick J
authors: PJ
authors: Tchou
authors: Mohamed
authors: M
authors: Kanj
authors: Thomas
authors: T
authors: Dresing
authors: Bruce D
authors: BD
authors: Lindsay
authors: Oussama
authors: O
authors: Wazni
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000601:surgery*; D001562:Benzimidazoles / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin